DARIOHEALTH CORP (DRIO)
US23725P2092 - Common Stock
We assign a fundamental rating of 2 out of 10 to DRIO. DRIO was compared to 40 industry peers in the Health Care Technology industry. DRIO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, DRIO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year DRIO has reported negative net income.
In the past year DRIO has reported a negative cash flow from operations.
In the past 5 years DRIO always reported negative net income.
In the past 5 years DRIO always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of DRIO (-65.90%) is worse than 66.67% of its industry peers.
With a Return On Equity value of -109.24%, DRIO is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.9% | ||
| ROE | -109.24% | ||
| ROIC | N/A |
ROA(3y)-65.86%
ROA(5y)-75.2%
ROE(3y)-93.72%
ROE(5y)-101.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRIO has a worse Gross Margin (29.39%) than 82.05% of its industry peers.
In the last couple of years the Gross Margin of DRIO has grown nicely.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.88%
GM growth 5Y4.19%
2. Health
2.1 Basic Checks
DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
DRIO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRIO has a worse debt to assets ratio.
2.2 Solvency
DRIO has an Altman-Z score of -5.68. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.68, DRIO is doing worse than 79.49% of the companies in the same industry.
DRIO has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.42, DRIO is in line with its industry, outperforming 43.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.68 |
ROIC/WACCN/A
WACC12.25%
2.3 Liquidity
A Current Ratio of 3.79 indicates that DRIO has no problem at all paying its short term obligations.
The Current ratio of DRIO (3.79) is better than 69.23% of its industry peers.
DRIO has a Quick Ratio of 3.38. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.38, DRIO is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 23.19% over the past year.
Looking at the last year, DRIO shows a very negative growth in Revenue. The Revenue has decreased by -26.41% in the last year.
Measured over the past years, DRIO shows a very strong growth in Revenue. The Revenue has been growing by 22.46% on average per year.
EPS 1Y (TTM)23.19%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q1.96%
Revenue 1Y (TTM)-26.41%
Revenue growth 3Y38.99%
Revenue growth 5Y22.46%
Revenue growth Q2Q-46.9%
3.2 Future
The Earnings Per Share is expected to grow by 17.72% on average over the next years. This is quite good.
The Revenue is expected to grow by 51.97% on average over the next years. This is a very strong growth
EPS Next Y-2%
EPS Next 2Y13.38%
EPS Next 3Y17.72%
EPS Next 5YN/A
Revenue Next Year83.18%
Revenue Next 2Y56.44%
Revenue Next 3Y53.65%
Revenue Next 5Y51.97%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DRIO. In the last year negative earnings were reported.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as DRIO's earnings are expected to grow with 17.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.38%
EPS Next 3Y17.72%
5. Dividend
5.1 Amount
DRIO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DARIOHEALTH CORP
NASDAQ:DRIO (4/24/2024, 7:00:01 PM)
After market: 1.4609 -0.04 (-2.61%)1.5
+0.05 (+3.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap44.16M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.9% | ||
| ROE | -109.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.39% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)23.19%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-26.41%
Revenue growth 3Y38.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y